Apo-Levocarb CR (carbidopa-levodopa cr) Treatment Report
Generic Name: Carbidopa-Levodopa CR
What is Apo-Levocarb CR?
Apo-Levocarb® CR is a Canadian brand name for the controlled release preparation of carbidopa/levodopa, an anti-Parkinson's agent. It is used to treat Parkinson's disease and parkinsonian-like symptoms. Off label it is used for restless leg syndrome.
Reasons taken & Efficacy
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Treat Parkinson's | 1 |
|
1 |
Mouse over the table for more information
Side Effects
Dosages
| 6 x 25 mg-100 mg daily | ||
|---|---|---|
1
|
||
Currently Taking Apo-Levocarb CR
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|
Adherence, Burden & Cost See details from patient evaluations ▼
See more information, including instructions, precautions, side effects, and interactions.
Patient Evaluations
See all 1 patient evaluation
-
- pennyfrenzy
- Sex: M
- Mouth/throat: mild
- Arms: moderate
- Chest: mild
- Legs: mild
- See profile
-
-
- pennyfrenzy
- 6 x 25 mg-100 mg daily
- since Jul 04, 2009
-
Efficacy
Major
for Treat Parkinson's
-
Side Effects
Mild
- See full evaluation
See all 1 patient evaluations
Report created on November 23, 2009.